Related references
Note: Only part of the references are listed.B cell-related gene signature and cancer immunotherapy response
Arian Lundberg et al.
BRITISH JOURNAL OF CANCER (2022)
Predictive and Prognostic Role of Peripheral Blood T-Cell Subsets in Triple-Negative Breast Cancer
Meng Li et al.
FRONTIERS IN ONCOLOGY (2022)
Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy
Vincent M. T. de Jong et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Cytoplasmic Colocalization of RXRα and PPARγ as an Independent Negative Prognosticator for Breast Cancer Patients
Wanting Shao et al.
CELLS (2022)
The Prognostic Impact of Retinoid X Receptor and Thyroid Hormone Receptor alpha in Unifocal vs. Multifocal/Multicentric Breast Cancer
Alaleh Zati Zehni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer
Hajime Kuroda et al.
BREAST CANCER (2021)
PPARgamma in Metabolism, Immunity, and Cancer: Unified and Diverse Mechanisms of Action
Miguel Hernandez-Quiles et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Clinicopathological Correlates of γδ T Cell Infiltration in Triple-Negative Breast Cancer
Florence Boissiere-Michot et al.
CANCERS (2021)
Prognostic value of tumor-infiltrating lymphocytes in estrogen receptor-positive and human epidermal growth factor receptor 2-negative breast cancer
Chikako Honda et al.
MOLECULAR AND CLINICAL ONCOLOGY (2021)
The Immunology of Hormone Receptor Positive Breast Cancer
Jonathan Goldberg et al.
FRONTIERS IN IMMUNOLOGY (2021)
PPARα Agonist Fenofibrate Enhances Cancer Vaccine Efficacy
Arezki Chekaoui et al.
CANCER RESEARCH (2021)
Prognostic value of tumour-infiltrating lymphocytes based on the evaluation of frequency in patients with oestrogen receptor-positive breast cancer
Jiajia He et al.
EUROPEAN JOURNAL OF CANCER (2021)
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer
Wanting Shao et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
Quantitative Assessment and Prognostic Associations of the Immune Landscape in Ovarian Clear Cell Carcinoma
Saira Khalique et al.
CANCERS (2021)
Cytoplasmic Localization of RXRα Determines Outcome in Breast Cancer
Alaleh Zati Zehni et al.
CANCERS (2021)
Mechanisms Governing Metabolic Heterogeneity in Breast Cancer and Other Tumors
Sayani Patra et al.
FRONTIERS IN ONCOLOGY (2021)
Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis
Guoxuan Gao et al.
BMC CANCER (2020)
Cytoplasmic and Nuclear Forms of Thyroid Hormone Receptor β1 Are Inversely Associated with Survival in Primary Breast Cancer
Wanting Shao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers
Wanting Shao et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Tumor-infiltrating lymphocytes (TILs) in ER+/HER2-breast cancer
C. Criscitiello et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Cytoplasmic versus nuclear THR alpha expression determines survival of ovarian cancer patients
Nina Ditsch et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Comprehensive analysis and establishment of a prediction model of alternative splicing events reveal the prognostic predictor and immune microenvironment signatures in triple negative breast cancer
Shanshan Yu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Nuclear Receptors as Potential Therapeutic Targets for Myeloid Leukemia
Pan Pan et al.
CELLS (2020)
The neoepitope landscape of breast cancer: implications for immunotherapy
Pooja Narang et al.
BMC CANCER (2019)
The Prognostic Impact of the Aryl Hydrocarbon Receptor (AhR) in Primary Breast Cancer Depends on the Lymph Node Status
Udo Jeschke et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Hormone Receptor Expression in Multicentric/Multifocal versus Unifocal Breast Cancer: Especially the VDR Determines the Outcome Related to Focality
Alaleh Zati Zehni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Tumor infiltrating lymphocytes in early breast cancer
Giancarlo Pruneri et al.
BREAST (2018)
Immune Infiltration in Invasive Lobular Breast Cancer
Christine Desmedt et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Immune Infiltration in Invasive Lobular Breast Cancer
Christine Desmedt et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Cancer-Associated Fibroblasts Correlate with Tumor-Associated Macrophages Infiltration and Lymphatic Metastasis in Triple Negative Breast Cancer Patients
Jing Zhou et al.
JOURNAL OF CANCER (2018)
Triple negative breast cancer - prognostic role of immune-related factors: a systematic review
Elisabeth Specht Stovgaard et al.
ACTA ONCOLOGICA (2018)
The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer
Kai Wang et al.
HUMAN PATHOLOGY (2017)
Vitamin D receptor, Retinoid X receptor and peroxisome proliferator-activated receptor γ are overexpressed in BRCA1 mutated breast cancer and predict prognosis
Sabine Heublein et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Natural and Structure-based RXR Ligand Scaffolds and Their Functions
Marta Dominguez et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)
Enhancing CD8+ T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy
Ying Zhang et al.
CANCER CELL (2017)
RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors
Sherene Loi et al.
CLINICAL CANCER RESEARCH (2016)
Clinical relevance of host immunity in breast cancer: from TILs to the clinic
Peter Savas et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Peroxisome proliferator-activated receptor alpha deficiency impairs regulatory T cell functions: Possible application in the inhibition of melanoma tumor growth in mice
Aziz Hichami et al.
BIOCHIMIE (2016)
MxA expression is associated with tumor-infiltrating lymphocytes and is a prognostic factor in triple-negative breast cancer
Young-Ae Kim et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Prognostic and predictive value of NanoString-based immune-related gene signatures in a neoadjuvant setting of triple-negative breast cancer: relationship to tumor-infiltrating lymphocytes
Hee Jin Lee et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R. Salgado et al.
ANNALS OF ONCOLOGY (2015)
Thyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways
Sabine Heublein et al.
PLOS ONE (2015)
Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study
M. V. Dieci et al.
ANNALS OF ONCOLOGY (2014)
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
S. Loi et al.
ANNALS OF ONCOLOGY (2014)
The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis
Ezzeldin M. Ibrahim et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
Sylvia Adams et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Modulation of RXR function through ligand design
Efren Perez et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2012)
Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+ tumor infiltrating lymphocytes in ductal and lobular breast cancers
Raoul Droeser et al.
BMC CANCER (2012)
Changes of tumor infiltrating lymphocyte subtypes before and after neoadjuvant endocrine therapy in estrogen receptor-positive breast cancer patients - an immunohistochemical study of cd8+and foxp3+using double immunostaining with correlation to the pathobiological response of the patients
Monica S. M. Chan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2012)
The Association between Vitamin D Receptor Expression and Prolonged Overall Survival in Breast Cancer
Nina Ditsch et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2012)
Correlation of thyroid hormone, retinoid X, peroxisome proliferator-activated, vitamin D and oestrogen/progesterone receptors in breast carcinoma
Nina Ditsch et al.
ONCOLOGY LETTERS (2012)
Casein-kinase-II-dependent phosphorylation of PPARγ provokes CRM1-mediated shuttling of PPARγ from the nucleus to the cytosol
Andreas von Knethen et al.
JOURNAL OF CELL SCIENCE (2010)
Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast
PP Leong et al.
IMMUNOLOGY LETTERS (2006)
Interaction of nuclear receptors with the Wnt/β-catenin/Tcf signaling axis:: Wnt you like to know?
DJ Mulholland et al.
ENDOCRINE REVIEWS (2005)
Inflammation and prognosis in colorectal cancer
K Klintrup et al.
EUROPEAN JOURNAL OF CANCER (2005)
The human peroxisome proliferator-activated receptor δ gene is a primary target of 1α,25-dihydroxyvitamin D3 and its nuclear receptor
TW Dunlop et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Interaction of nuclear receptor ligands with the vitamin D signaling pathway in prostate cancer
DM Peehl et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2004)
Share Paper
